Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement
FE Stuurman, B Nuijen, JH Beijnen… - Clinical …, 2013 - Springer
The use of oral anticancer drugs has increased during the last decade, because of patient
preference, lower costs, proven efficacy, lack of infusion-related inconveniences, and the …
preference, lower costs, proven efficacy, lack of infusion-related inconveniences, and the …
[引用][C] Oral Anticancer Drugs: Mechanisms of Low Bioavailability and Strategies for Improvement
FE Stuurman, B Nuijen, JH Beijnen… - Clinical …, 2013 - cir.nii.ac.jp
Oral Anticancer Drugs: Mechanisms of Low Bioavailability and Strategies for Improvement |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
Oral Anticancer Drugs: Mechanisms of Low Bioavailability and Strategies for Improvement
FE Stuurman, B Nuijen, JH Beijnen… - Clinical …, 2013 - search.proquest.com
The use of oral anticancer drugs has increased during the last decade, because of patient
preference, lower costs, proven efficacy, lack of infusion-related inconveniences, and the …
preference, lower costs, proven efficacy, lack of infusion-related inconveniences, and the …
Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement
FE Stuurman, B Nuijen, JH Beijnen… - Clinical …, 2013 - pubmed.ncbi.nlm.nih.gov
The use of oral anticancer drugs has increased during the last decade, because of patient
preference, lower costs, proven efficacy, lack of infusion-related inconveniences, and the …
preference, lower costs, proven efficacy, lack of infusion-related inconveniences, and the …
[PDF][PDF] Oral Anticancer Drugs: Mechanisms of Low Bioavailability and Strategies for Improvement
FE Stuurman, B Nuijen, JH Beijnen… - Clin …, 2013 - researchgate.net
The use of oral anticancer drugs has increased during the last decade, because of patient
preference, lower costs, proven efficacy, lack of infusion-related inconveniences, and the …
preference, lower costs, proven efficacy, lack of infusion-related inconveniences, and the …
Oral Anticancer Drugs: Mechanisms of Low Bioavailability and Strategies for Improvement.
F Stuurman, B Nuijen, J Beijnen… - Clinical …, 2013 - search.ebscohost.com
The use of oral anticancer drugs has increased during the last decade, because of patient
preference, lower costs, proven efficacy, lack of infusion-related inconveniences, and the …
preference, lower costs, proven efficacy, lack of infusion-related inconveniences, and the …
[引用][C] Oral Anticancer Drugs: Mechanisms of Low Bioavailability and Strategies for Improvement
FE STUURMAN, B NUIJEN… - Clinical …, 2013 - pascal-francis.inist.fr
Oral Anticancer Drugs: Mechanisms of Low Bioavailability and Strategies for Improvement
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Oral Anticancer Drugs: Mechanisms of Low Bioavailability and Strategies for Improvement
FE Stuurman, B Nuijen, JH Beijnen… - Clinical …, 2013 - infona.pl
The use of oral anticancer drugs has increased during the last decade, because of patient
preference, lower costs, proven efficacy, lack of infusion-related inconveniences, and the …
preference, lower costs, proven efficacy, lack of infusion-related inconveniences, and the …
Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement.
FE Stuurman, B Nuijen, JH Beijnen… - Clinical …, 2013 - europepmc.org
The use of oral anticancer drugs has increased during the last decade, because of patient
preference, lower costs, proven efficacy, lack of infusion-related inconveniences, and the …
preference, lower costs, proven efficacy, lack of infusion-related inconveniences, and the …